AI Market Mood: Stock Dashboard
ZBIO
Fundamental
Company: Zenas Biopharma Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -4.53
Insider Own: 59.43%
Shs Outstand: 42.21M
Perf Week: 24.21%
Market Cap: 1.43B
Forward P/E: -
EPS next Y: -4.50
Insider Trans: 3.86%
Shs Float: 21.78M
Perf Month: 32.34%
Enterprise Value: 1.14B
PEG: -
EPS next Q: -1.00
Inst Own: 35.55%
Short Float: 30.16%
Perf Quarter: -23.77%
Income: -189.90M
P/S: 95.48
EPS this Y: 65.34%
Inst Trans: 9.31%
Short Ratio: 8.57
Perf Half Y: 54.40%
Sales: 15.00M
P/B: 5.73
EPS next Y Percentage: -9.13%
ROA: -52.35%
Short Interest: 6.57M
Perf YTD: -26.52%
Book/sh: 4.65
P/C: 4.92
EPS next 5Y: 31.84%
ROE: -68.33%
52W High: 44.60 -40.18%
Perf Year: 301.20%
Cash/sh: 5.42
P/FCF: -
EPS past 3/5Y: -9.85% -
ROIC: -96.59%
52W Low: 6.11 336.66%
Perf 3Y: -
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: 99.47%
Volatility W: 11.87%
Volatility M: 9.39%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 76.14
EPS Y/Y TTM: -38.04%
Oper. Margin: -1304.64%
ATR (14): 2.42
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 5.66
Sales Y/Y TTM: -70.00%
Profit Margin: -1265.99%
RSI (14): 59.35
Recom: 1.25
Dividend Gr. 3/5Y: - -
Current Ratio: 5.66
EPS Q/Q: -32.20%
SMA20: 22.75%
Beta: -2.03
Target Price: 40.75
Payout: -
Debt/Eq: 0.00
Sales Q/Q: -
SMA50: -2.70%
Rel Volume: 0.55
Prev Close: 26.77
Employees: 130
LT Debt/Eq: 0.00
Earnings: Nov 12 BMO
SMA200: 26.18%
Avg Volume: 766.48K
Price: 26.68
IPO: Sep 13, 2024
Option/Short: Yes / Yes
EPS/Sales Surpr.: -17.57% -100.00%
Trades:
Volume: 423,480
Change: -0.34%
Technical:
Latest News:
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 million valuation in US IPO somewhat bullish
ZBIO
Summary: Zenas BioPharma aims for a valuation of up to $689.7 million in its U.S. IPO, backed by Bristol-Myers Squibb and targeting to raise $211.7 million by offering 11.76 million shares.
Full article2024-09-06T12:28:43Z